CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,574 | -13.0% | 28,877 | -0.2% | 0.01% | -6.7% |
| Q2 2023 | $388,000 | +59.0% | 28,942 | +96.7% | 0.02% | +50.0% |
| Q1 2023 | $244,000 | -11.3% | 14,715 | -0.7% | 0.01% | -9.1% |
| Q4 2022 | $275,000 | -79.9% | 14,818 | -93.8% | 0.01% | -75.0% |
| Q2 2021 | $1,370,000 | +24.7% | 238,281 | -0.1% | 0.04% | +18.9% |
| Q1 2021 | $1,099,000 | +37.5% | 238,489 | -0.3% | 0.04% | +37.0% |
| Q4 2020 | $799,000 | -8.3% | 239,292 | -18.4% | 0.03% | -15.6% |
| Q3 2020 | $871,000 | -40.7% | 293,220 | -7.8% | 0.03% | -42.9% |
| Q2 2020 | $1,469,000 | – | 317,910 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |